These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16628730)

  • 1. Analysis of serum granulysin in patients with hematopoietic stem-cell transplantation: its usefulness as a marker of graft-versus-host reaction.
    Nagasawa M; Isoda T; Itoh S; Kajiwara M; Morio T; Shimizu N; Ogawa K; Nagata K; Nakamura M; Mizutani S
    Am J Hematol; 2006 May; 81(5):340-8. PubMed ID: 16628730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
    Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granzymes A and B serum levels in allo-SCT.
    Kircher B; Schumacher P; Nachbaur D
    Bone Marrow Transplant; 2009 May; 43(10):787-91. PubMed ID: 19079312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft.
    Laurin D; Hannani D; Pernollet M; Moine A; Plumas J; Bensa JC; Cahn JY; Garban F
    Transfusion; 2010 Feb; 50(2):418-28. PubMed ID: 19843288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulysin in human serum as a marker of cell-mediated immunity.
    Ogawa K; Takamori Y; Suzuki K; Nagasawa M; Takano S; Kasahara Y; Nakamura Y; Kondo S; Sugamura K; Nakamura M; Nagata K
    Eur J Immunol; 2003 Jul; 33(7):1925-33. PubMed ID: 12884856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Avanzini MA; Maccario R; Locatelli F; Giebel S; Santos CD; Bernardo ME; Pagliara D; Montagna D; Longo S; Amendola G; Marconi M
    Exp Hematol; 2006 Oct; 34(10):1429-34. PubMed ID: 16982336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum stem cell growth factor for monitoring hematopoietic recovery following stem cell transplantation.
    Ito C; Sato H; Ando K; Watanabe S; Yoshiba F; Kishi K; Furuya A; Shitara K; Sugimoto S; Kohno H; Hiraoka A; Hotta T
    Bone Marrow Transplant; 2003 Aug; 32(4):391-8. PubMed ID: 12900775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining altered levels of effector transcripts in circulating T cells with a marker of endothelial injury is specific for active graft-versus-host disease.
    Biedermann BC; Tsakiris DA; Gregor M; Pober JS; Gratwohl A
    Bone Marrow Transplant; 2003 Dec; 32(11):1077-84. PubMed ID: 14625579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y; Deng YB; Huang YJ; Wang Y
    Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of C-reactive protein release following allogeneic stem cell transplantation are correlated with leukemic relapse.
    Min CK; Kim SY; Eom KS; Kim YJ; Kim HJ; Lee S; Kim DW; Lee JW; Min WS; Kim CC
    Bone Marrow Transplant; 2006 Mar; 37(5):493-8. PubMed ID: 16435015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation.
    Wolf D; Wolf AM; Fong D; Rumpold H; Strasak A; Clausen J; Nachbaur D
    Transplantation; 2007 Apr; 83(8):1107-13. PubMed ID: 17452902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease.
    Imoto S; Oomoto Y; Murata K; Das H; Murayama T; Kajimoto K; Sugimoto T; Gomyo H; Nakagawa T; Nishimura R; Koizumi T
    Int J Hematol; 2000 Jul; 72(1):92-7. PubMed ID: 10979216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma nitric oxide is associated with the occurrence of moderate to severe acute graft-versus-host disease in haemopoietic stem cell transplant recipients.
    Choi IC; Fung PC; Leung AY; Lie AK; Liang R
    Haematologica; 2001 Sep; 86(9):972-6. PubMed ID: 11532626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of angiopoietins and cell-derived microparticles after stem cell transplantation.
    Nomura S; Ishii K; Inami N; Kimura Y; Uoshima N; Ishida H; Yoshihara T; Urase F; Maeda Y; Hayashi K
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):766-74. PubMed ID: 18541195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation.
    Min CK; Kim SY; Lee MJ; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Kim CC; Cho CS
    Bone Marrow Transplant; 2006 Jul; 38(2):149-56. PubMed ID: 16751784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation.
    Nomura S; Ishii K; Inami N; Uoshima N; Ishida H; Yoshihara T; Kitayama H; Hayashi K
    Transpl Immunol; 2007 Nov; 18(2):115-21. PubMed ID: 18005854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The initial phase of graft-versus-host disease is associated with a decrease of CD4+CD25+ regulatory T cells in the peripheral blood of patients after allogeneic stem cell transplantation.
    Schneider M; Munder M; Karakhanova S; Ho AD; Goerner M
    Clin Lab Haematol; 2006 Dec; 28(6):382-90. PubMed ID: 17105491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.